Stockscreener 앱 받기
0.65%
시간 외 거래:
Pfizer Inc 주식(PFE)의 최신 뉴스
How to read the order book for Pfizer Inc.July 2025 Weekly Recap & Weekly High Potential Alerts - Newser
Pfizer's Golden Cross Signals Strength: How to Play the Stock - Yahoo Finance
Acne Medicine Market Size Projected to Reach USD 23.33 Billion by 2034 - GlobeNewswire Inc.
A Look at Pfizer’s Valuation After FDA Approval of Next-Gen COVID Vaccine for Older Adults and High-Risk Groups - Yahoo Finance
Stock Analysis | Pfizer OutlookNavigating Mixed Signals in a Volatile Market - AInvest
Relative strength of Pfizer Inc. in sector analysisIPO Watch & Long-Term Investment Growth Plans - Newser
Advanced analytics toolkit walkthrough for Pfizer Inc.Market Trend Review & Stepwise Trade Signal Implementation - Newser
Using flow based indicators on Pfizer Inc.Earnings Recap Summary & Reliable Entry Point Trade Alerts - Newser
Should FDA Approval of Updated COVID Vaccine for Vulnerable Groups Prompt a Closer Look at Pfizer (PFE)? - simplywall.st
Is Pfizer Inc. trending in predictive chart modelsRecession Risk & Real-Time Market Trend Scan - Newser
Pfizer (PFE) Announces FDA Approval of sBLA for Pfizer-BioNTech COVID-19 Vaccine - MSN
Chart overlay techniques for tracking Pfizer Inc.Trade Volume Report & Low Risk High Reward Ideas - Newser
Price momentum metrics for Pfizer Inc. explainedPortfolio Value Report & AI Powered Market Trend Analysis - Newser
Developing predictive dashboards with Pfizer Inc. dataEarnings Overview Report & Daily Profit Maximizing Trade Tips - Newser
Published on: 2025-08-30 04:48:26 - Newser
Pfizer Sued Over Depo-Provera Brain Tumor Risks - Law360
UPC sees rising small molecule litigation with Pfizer in the hot seat - Life Sciences Intellectual Property Review
Measuring Pfizer Inc.’s beta against major indicesMarket Rally & Smart Investment Allocation Tips - Newser
Precision Trading with Pfizer Inc. (PFE) Risk Zones - news.stocktradersdaily.com
Moderna and Freshfields win against BioNTech and Pfizer at UK Court of Appeal - JUVE Patent
Is It Too Late to Sell Pfizer Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Pfizer (PFE) Stock Price, News & Analysis - MarketBeat
Pfizer Shares Drop 1.87% on $1.07B Top Volume as Patent Cliff and Medicare Reforms Loom R&D Setbacks Add Pressure Amid Cost-Cutting Hopes - AInvest
Pfizer Inc. - Britannica
COVID-19 Vaccines: Pfizer Arguments To Keep EUA Failed To Persuade US FDA’s Prasad - insights.citeline.com
Is Pfizer Stock A Sell On Its Severely Limited Covid Shots? - Investor's Business Daily
At $25 Is Pfizer Stock Deep Value Or A Falling Knife? - Forbes
Can Pfizer's Cost Cuts And New Drugs Offset Upcoming Headwinds? - Barchart.com
Can Pfizer's Cost Cuts and New Drugs Offset Upcoming Headwinds? - The Globe and Mail
0.36%
0.92%
자본화:
|
볼륨(24시간):